In this study, our data provide evidence that EE treatment promoted angiogenesis by increasing the protein expression of VEGF and CD34 in the ischemic penumbra through astrocytic IL-17A during the recovery phase after stroke. The gene discussed is IL17A; the disease is stroke disorder.